OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings

Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
 * Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
 * Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

Knight Research Group Activities
Want to join us? All are invited!
 * To get on the listserve:
 * Email: majordomoATohsu.edu (must be sent as a plain text email)
 * subject: subscribe oncres
 * text box: subscribe oncres


 * We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
 * Fridays 9:30-10:30 AM - see schedule below
 * Breakfast provided by the Knight!


 * Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations
Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB


 * Scheduling In Progress

Schedule
{| border="1" cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse; width:780px"
 * align="center" style="background:#f0f0f0;"|Date
 * align="center" style="background:#f0f0f0;"|Presenters
 * align="center" style="background:#f0f0f0;"|Topic
 * align="center" style="background:#f0f0f0;"|Links & Comments


 * 09/24/2010
 * Gary Thomas
 * Connecting Membrane Traffic to p53 Homeostasis
 * 10/8/2010
 * Lopez Lab
 * Mechanisms of deltaNASPP2 function: a novel isoform of the ASPP2 tumor suppressor
 * 10/22/2010
 * Tania Vu
 * Molecular Imaging of Tyrosine Kinase Signaling Using Quantum Dot Technology
 * 11/12/2010
 * Jeffrey Tyner
 * Functional Screening for Target Identification in Leukemia Patients
 * A discussion of novel tyrosine kinase targets and therapies for leukemia patients identified by functional screening with siRNA and small-molecule kinase inhibitors.
 * 12/10/2010
 * Yuangang Liu
 * NF-kappaB repression by PIAS3 mediated RelA sumoylation
 * 1/14/2011
 * Steven Jacques
 * Early detection of cancer by optical sensing of abnormal nuclear nanoarchitecture
 * 1/28/2011
 * Laura Hays
 * The Multifunctionality of the Fanconi Anemia/BRCA Pathway in Tumor Suppression
 * 2/11/2011
 * Thayer Lab
 * Identification of autosomal loci that control chromosome-wide replication timing and stability
 * 2/25/2011
 * Sears Lab
 * Targeting c-Myc through the tumor suppressor phosphatase, PP2A, for the treatment of breast and pancreatic cancer
 * 3/11/2011
 * Dai Lab
 * Ribosomal protein regulation of p53 and c-Myc in response to ribosomal stress
 * 3/25/2011
 * NO MEETING
 * Spring Break
 * 4/8/2011 *time change: 9-9:50 AM
 * Lev Fedorov
 * Targeting of Rheb oncogene
 * Chris Corless will present the OHSU biolobrary website at 9:50am
 * 4/22/2011
 * Wong Lab
 * CD166 as an intriguingly targetable molecule for cancer
 * 5/13/2011
 * Thomas O'Hare
 * Pulsed-exposure to tyrosine kinase inhibitors in CML: Oncogenic shock or a hidden drug habit?
 * 5/27/2011
 * Martin Pike
 * Manipulation of Hypoxic Stress Responses to Increase Anti-angiogenic Efficacy: Perfusion MRI studies of Intracranial Glioma
 * 6/10/2011
 * Lisa Wood
 * 3/25/2011
 * NO MEETING
 * Spring Break
 * 4/8/2011 *time change: 9-9:50 AM
 * Lev Fedorov
 * Targeting of Rheb oncogene
 * Chris Corless will present the OHSU biolobrary website at 9:50am
 * 4/22/2011
 * Wong Lab
 * CD166 as an intriguingly targetable molecule for cancer
 * 5/13/2011
 * Thomas O'Hare
 * Pulsed-exposure to tyrosine kinase inhibitors in CML: Oncogenic shock or a hidden drug habit?
 * 5/27/2011
 * Martin Pike
 * Manipulation of Hypoxic Stress Responses to Increase Anti-angiogenic Efficacy: Perfusion MRI studies of Intracranial Glioma
 * 6/10/2011
 * Lisa Wood
 * Thomas O'Hare
 * Pulsed-exposure to tyrosine kinase inhibitors in CML: Oncogenic shock or a hidden drug habit?
 * 5/27/2011
 * Martin Pike
 * Manipulation of Hypoxic Stress Responses to Increase Anti-angiogenic Efficacy: Perfusion MRI studies of Intracranial Glioma
 * 6/10/2011
 * Lisa Wood
 * 6/10/2011
 * Lisa Wood
 * 6/10/2011
 * Lisa Wood